Business

NeuroScientific locks in key US FDA meeting

16 hours ago8 views0

NeuroScientific has locked in a key meeting with the US FDA for its StemSmart technology aimed at treating refractory Crohn’s disease in a planned Phase 2 trial.

Business / Companies

Brisbane Times – Business

From petri dish to patient:biotech’s formidable obstacle course

Bulls N’ Bears follows a biotech breakthrough from the laboratory to the patient and examines ...

12 hours ago

Business

Murdoch left Melbourne Storm to a betting entrepreneur. What a howler

That a Swedish private equity firm is now cued up as a likely buyer for ...

13 hours ago

Business

AI boom a copper boon, not a bust

The rise of AI is driving a huge new demand for copper to power its ...

13 hours ago

Now Reading

NeuroScientific locks in key US FDA meeting

1min read

0 %

NeuroScientific locks in key US FDA meeting

Transurban’s Brisbane revenue surges at double rate of traffic growth

It might terrify Gen Z, but the humble phone call is a wonderful thing

Leave a reply Cancel reply

More in:Business

From petri dish to patient:biotech’s formidable obstacle course

Murdoch left Melbourne Storm to a betting entrepreneur. What a howler

AI boom a copper boon, not a bust

Posts List

It might terrify Gen Z, but the humble phone call is a wonderful thing